Proteomics International secures US patent until 2041
The USPTO has granted a patent extending until March 2041 to Proteomics International Laboratories (ASX:PIQ) for its non-invasive endometriosis diagnostic blood test.
The USPTO has granted a patent extending until March 2041 to Proteomics International Laboratories (ASX:PIQ) for its non-invasive endometriosis diagnostic blood test.
QBE Insurance (ASX:QBE) announced that its Australia Pacific CEO, Sue Houghton, will retire at the end of 2026.
Frasers Group applies to Australia's Takeovers Panel following the rejection of its $390M takeover bid for Accent Group (ASX:AX1).
SPC Global (ASX:SPG) announced that its normalised EBITDA remains on track to achieve approximately 25% growth.
Adairs (ASX:ADH) announced an expected statutory net loss after tax of approximately $43 million for the 2026 financial year.
SSH Group (ASX:SSH) reports a 75% increase in pro forma revenue to $65.6 million for FY26, driven by its EMS acquisition.
Nexus Minerals (ASX:NXM) acquired the remaining 10% interest in the Pinnacles Joint Venture Project to reach 100% ownership.
ResMed (ASX:RMD) signed an agreement to sell its MatrixCare software business to private equity firm Frazier Healthcare Partners.
Predictive Discovery (ASX:PDI) poured a combined 64,026 ounces of gold during the quarter ended June 30.
Gold producer Ramelius Resources (ASX:RMS) achieved its full-year production guidance by delivering 192,182 ounces of gold.
Alkane Resources (ASX:ALK) produced 42,491 ounces of gold equivalent during the June quarter to achieve its annual targets.
Cogstate (ASX:CGS) executed US$89 million in full-year net sales contracts, representing a 116% increase over the previous year.